Novartis and Sanofi Urge EU to Raise Drug Prices
Key Points: 1. European pharma leaders push for higher drug prices to boost global competitiveness. 2. CEOs warn EU may ...
Tag: Pharma
Eli Lilly Takes Legal Action Against Telehealth Startups
Key Points: 1. Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain ...
FDA Approves Dupilumab for Chronic Spontaneous Urticaria
Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Drugmakers Increase Prices on Over 250 Medications Pharmaceutical companies have raised prices on over 250 branded medications in the U.S., ...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Blood Test Could Replace Colonoscopies Forget the prep kits and uncomfortable procedures—there’s a new blood test that might change ...
Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer
1. In this randomized controlled trial, in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced ...
![Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]](https://www.2minutemedicine.com/wp-content/uploads/2015/04/NOVAMOXIN_antibiotic-350x250.jpg)
Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections
1. In this randomized controlled trial, among hospitalized patients with a bloodstream infection, seven days of antibiotic treatment was found ...
Trastuzumab emtansine improves outcomes in residual HER2-positive breast cancer
1. In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with residual human epidermal ...
Ponsegromab improves boy weight in cancer-related cachexia
1. Ponsegromab significantly increased body weight in patients with cancer cachexia and elevated GDF-15 levels compared to placebo at 12 ...
